We are live on
!
Find out more
SWM
Strategic Wealth Management Portfolio holdings
AUM
$202M
1-Year Est. Return
9.35%
This Fund
S&P 500
This Quarter
Est. Return
-1.36%
1 Year Est. Return
+9.35%
3 Year Est. Return
+52.78%
5 Year Est. Return
+60.52%
10 Year Est. Return
–
AUM
$95.5M
AUM Growth
–
Cap. Flow
+$98.8M
Cap. Flow
% of AUM
103.51%
Top 10 Holdings %
Top 10 Hldgs %
75.37%
Holding
27
New
27
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$10.9M |
| 2 |
iShares Russell 2000 Value ETF
IWN
|
+$8.1M |
| 3 |
SPDR Gold Trust
GLD
|
+$7.34M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$7.31M |
| 5 |
iShares MSCI Spain ETF
EWP
|
+$7.23M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0.79% |
Similar funds
IFG
ACM
APSP
FAC
MC
KM
TI
GC
Strategic Wealth Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Strategic Wealth Management, which disclosed 27 positions worth $95.5M. Its ten largest holdings account for 75% of the portfolio.
Its largest position is iShares Biotechnology ETF: 187,932 shares worth $10.9M.
By sector, the portfolio is most concentrated in Healthcare at 0.79% of assets.
- Strategic Wealth Management's largest Q2 2013 buy was iShares Biotechnology ETF: 187,932 shares worth $10.9M.
- Strategic Wealth Management's ten largest holdings make up 75% of its $95.5M portfolio in Q2 2013.
- Strategic Wealth Management disclosed 27 positions in Q2 2013, its first 13F filing on record.
Based on Strategic Wealth Management's 13F filing for Q2 2013, filed 22 Jul 2013.